# Phase 1/2 trial of vorinostat in patients with sickle cell disease who have not benefitted from hydroxyurea

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/phase-1-2-trial-of-vorinostat-in-patients-with-sickle-cell-disease-who-have-not/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Maureen Okam,Erica B. Esrick,Elyse Mandell,Federico Campigotto,Donna Neuberg,Benjamin L. Ebert |
| Citations | 33 |
| DOI | 10.1182/blood-2015-03-635391 |
| Fields | Medicine |
| Open Access | true |
| OA Status | bronze |
| OA URL | https://ashpublications.org/blood/article-pdf/125/23/3668/1388194/3668.pdf |
| OpenAlex ID | https://openalex.org/W810874565 |
| PMID | 26045597 |
| Type | article |
| Year | 2015 |

## Paper authors

- [Maureen Okam](https://scholariq.org/researchers/maureen-okam/)
- [Elyse Mandell](https://scholariq.org/researchers/elyse-mandell/)

## Paper journal

- [Blood](https://scholariq.org/journals/blood/)

## Paper primary topic

- [Hemoglobinopathies and Related Disorders](https://scholariq.org/topics/hemoglobinopathies-and-related-disorders/)

## Paper topics

- [Hemoglobinopathies and Related Disorders](https://scholariq.org/topics/hemoglobinopathies-and-related-disorders/)
- [Myeloproliferative Neoplasms: Diagnosis and Treatment](https://scholariq.org/topics/myeloproliferative-neoplasms-diagnosis-and-treatment/)
- [Blood groups and transfusion](https://scholariq.org/topics/blood-groups-and-transfusion/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.